Literature DB >> 7508391

Inducible nitric-oxide-synthase mRNA is transiently expressed and destroyed by a cycloheximide-sensitive process.

T Evans1, A Carpenter, J Cohen.   

Abstract

Nitric oxide is a mediator of a wide range of physiological processes. It is produced by an enzyme family, the nitric-oxide synthases, one form of which is induced in many cells following stimulation with cytokines and lipopolysaccharide. The aim of the experiments reported in this study was to investigate the regulation of mRNA expression for this inducible nitric-oxide synthase in smooth muscle cells and macrophages. Stimulation of these cells with cytokines and lipopolysaccharide results in a marked elevation of nitric-oxide-synthase mRNA levels, which however do not remain elevated, but reach a maximum at 3-6 h after stimulation before returning to baseline levels over the next 20 h. Enzyme activity, however, remained virtually constant for 48 h following stimulation. Inspection of the 3' untranslated segment of both murine and human inducible nitric-oxide-synthase mRNAs showed the presence of a conserved AU-rich octanucleotide sequence, previously identified in cytokine and oncogene mRNAs and shown to mediate mRNA instability. A particular feature of the breakdown of mRNAs bearing this sequence is that degradation is prevented by protein-synthesis inhibition. We show in this study that the half-life of inducible nitric-oxide-synthase mRNA is 6 h and that in the presence of an inhibitor of protein synthesis this breakdown is prevented. Thus, the mRNA for inducible nitric-oxide synthase shares some features in common with cytokines such as the transient expression and decay of its mRNA which can be prevented by protein-synthesis inhibition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508391     DOI: 10.1111/j.1432-1033.1994.tb19972.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

Review 1.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

2.  Flow dependence and time constant of the change in nitric oxide concentration measured in the vascular media.

Authors:  S Mochizuki; M Goto; Y Chiba; Y Ogasawara; F Kajiya
Journal:  Med Biol Eng Comput       Date:  1999-07       Impact factor: 2.602

3.  Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin.

Authors:  R Korhonen; H Kankaanranta; A Lahti; M Lähde; R G Knowles; E Moilanen
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

Review 4.  The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells.

Authors:  D L Eizirik; M Flodström; A E Karlsen; N Welsh
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

5.  Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta.

Authors:  A Papapetropoulos; G Abou-Mohamed; N Marczin; F Murad; R W Caldwell; J D Catravas
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

6.  Increased intracellular Ca2+ selectively suppresses IL-1-induced NO production by reducing iNOS mRNA stability.

Authors:  Y Geng; M Lotz
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

7.  Middle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase.

Authors:  D Ghigo; M Arese; R Todde; A Vecchi; F Silvagno; C Costamagna; Q G Dong; M Alessio; R Heller; R Soldi; F Trucco; G Garbarino; G Pescarmona; A Mantovani; F Bussolino; A Bosia
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

8.  Modulation of nitric oxide synthase activity in macrophages.

Authors:  P G Jorens; K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.